About this trial
Patients requiring thoracic reconstruction often suffer from numerous comorbidities, such as obesity, diabetes, atherosclerosis and cardiovascular diseases, respiratory diseases. The clinical picture of these patients must be carefully stabilized in the preoperative period since the listed diseases are associated with a poor reconstructive outcome. Furthermore, it is necessary to preoperatively determine the spirometric characteristics in cases where the intervention may alter the respiratory dynamics to evaluate the patient's ability to tolerate the procedure. The primary objective of the study is to identify the best diagnostic-therapeutic approach in cases of complex chest wall defects, retrospectively evaluating the outcomes and therapeutic choices implemented, through a reassessment of the interventions performed and the clinical progress of patients undergoing complex thoracic and sternal reconstruction interventions managed in a multidisciplinary and non-multidisciplinary manner
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
All patients undergoing sternal or thoracic reconstruction in collaboration or not with the Reconstructive Plastic Surgery Unit
Obtaining informed consent
Disqualifiers
None
Trial population
All patients meeting the inclusion criteria will be counted, starting from January 1, 2010 to January 1, 2023. It is estimated that approximately 100 patients will meet the inclusion criteria.
Trial design
Cohort
Retrospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Technical Success
Thechnical success is evaluated by duration of surgery, complications and need for reoperation, and hospitalization time
Sponsors and contacts
Click on the lead sponsor to view all of their trials.